Green Thumb Industries (GTBIF) Cash from Operations (2019 - 2026)
Green Thumb Industries (GTBIF) posted Cash from Operations of 75799000.0 for Q1 2026, down 15.91% on a QoQ basis from 90141000.0 in Q4 2025, and up 2.13% year-over-year from 74219000.0 in Q1 2025.
Green Thumb Industries (GTBIF) Cash from Operations (2019 - 2026) Analysis & Trends
Green Thumb Industries' Cash from Operations history runs 8 years deep, the most recent figure standing at 75799000.0 for Q1 2026.
- Quarterly Cash from Operations rose 2.13% year-over-year to 75799000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 296506000.0 (up 59.95% YoY) and the FY2025 annual result came in at 294926000.0, up 51.1% from the prior year.
- Cash from Operations was 75799000.0 for Q1 2026 at Green Thumb Industries, down from 90141000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 90141000.0 in Q4 2025 and bottomed at 15462000.0 in Q2 2022.
- A 5-year average of 55849411.76 and a median of 60844000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations sank 278.94% — and 2023, when it soared 218.46%.
- Green Thumb Industries' Cash from Operations stood at 70344000.0 in 2022, then grew by 1.07% to 71096000.0 in 2023, then plunged by 39.04% to 43338000.0 in 2024, then soared by 108.0% to 90141000.0 in 2025, then retreated by 15.91% to 75799000.0 in 2026.
- Business Quant data shows GTBIF's Cash from Operations at 75799000.0 in Q1 2026, 90141000.0 in Q4 2025, and 74119000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 75.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.80 Mn |
| Mar 31, 2026 | 75.80 Mn |
| Dec 31, 2025 | 90.14 Mn |
| Dec 31, 2025 | 90.14 Mn |
| Sep 30, 2025 | 74.12 Mn |
| Sep 30, 2025 | 74.12 Mn |
| Jun 30, 2025 | 56.45 Mn |
| Jun 30, 2025 | 56.45 Mn |
| Mar 31, 2025 | 74.22 Mn |
| Mar 31, 2025 | 74.22 Mn |
| Dec 31, 2024 | 43.34 Mn |
| Dec 31, 2024 | 43.34 Mn |
| Sep 30, 2024 | 47.67 Mn |
| Sep 30, 2024 | 47.67 Mn |
| Jun 30, 2024 | 20.15 Mn |
| Jun 30, 2024 | 20.15 Mn |
| Mar 31, 2024 | 84.02 Mn |
| Mar 31, 2024 | 84.02 Mn |
| Dec 31, 2023 | 71.10 Mn |
| Dec 31, 2023 | 71.10 Mn |